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Abstract
Introduction: Acute kidney injury (AKI) is a serious complication in critically ill patients admitted to the Intensive
Care Unit (ICU). We hypothesized that ICU survivors with AKI would have a worse health-related quality of life
(HRQOL) outcome than ICU survivors without AKI.
Methods: We performed a long-term prospective observational study. Patients admitted for > 48 hours in a
medical-surgical ICU were included and divided in two groups: patients who fulfilled RIFLE criteria for AKI and
patients without AKI. We used the Short-Form 36 to evaluate HRQOL before admission (by proxy within 48 hours
after admission of the patient), at ICU discharge, hospital discharge, 3 and 6 months following ICU discharge (all by
patients). Recovery in HRQOL from ICU-admission onwards was assessed using linear mixed modelling.
Results: Between September 2000 and January 2007 all admissions were screened for study participation. We
included a total of 749 patients. At six months after ICU discharge 73 patients with AKI and 325 patients without
AKI could be evaluated. In survivors with and without AKI, the pre-admission HRQOL (by proxy) and at six months
after ICU discharge was significantly lower compared with an age matched general population. Most SF-36
dimensions changed significantly over time from ICU discharge. Change over time of HRQOL between the
different AKI Rifle classes (Risk, Injury, Failure) showed no significant differences. At ICU discharge, scores were
lowest in the group with AKI compared with the group without AKI for the physical functioning, role-physical and
general health dimensions. However, there were almost no differences in HRQOL between both groups at six
months.
Conclusions: The pre-admission HRQOL (by proxy) of AKI survivors was significantly lower in two dimensions
compared with the age matched general population. Six months after ICU discharge survivors with and without
AKI showed an almost similar HRQOL. However, compared with the general population with a similar age, HRQOL
was poorer in both groups.
Introduction
Acute kidney injury (AKI) is a common finding among
patients in the intensive care unit (ICU) [1] and occurs in
at least 35% to 70% of ICU admissions and approximately
10% will require renal replacement therapy (RRT). AKI
mortality is related to severity of injury with a high mortal-
ity rate despite the advances in RRT [2]. Furthermore, AKI
is frequently a manifestation of multiple organ dysfunction
syndrome, and this in itself may explain the high mortality
[3]. The cost-effectiveness and rationale both for health-
related quality of life (HRQOL) and long-term mortality
after initial recovery of ICU patients with AKI have been
challenged [4]. An important aspect in this discussion is
the HRQOL of patients who have survived AKI and subse-
quently require RRT in the ICU. Several studies reported
that the HRQOL of patients with AKI and treated with
RRT in the ICU is impaired [2,3,5-8]. Important short-
comings of many studies in patients with AKI are not only
the lack of knowledge regarding the HRQOL before the
AKI and before the ICU stay but also long-term outcomes
in terms of mortality and HRQOL. Other studies showed
that many patients requiring ICU admission have a lower
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HRQOL before hospital admission [9-11]. Therefore, the
first aims of our study were to measure HRQOL before
ICU admission and to assess the impact of ICU stay by fol-
lowing the evolution of HRQOL in surviving patients with
AKI and those without AKI, up to 6 months after ICU dis-
charge. The second aims were to compare the HRQOL of
the patients with AKI with that of patients without AKI
and to compare both groups with an age-matched general
population. We hypothesized that survivors of AKI would
have a worse HRQOL outcome than ICU survivors with-
out AKI.
Materials and methods
We performed a long-term prospective observational
study in a 10-bed closed-format (intensivist led) mixed
medical-surgical ICU of Gelre Hospital, a 654-bed univer-
sity-affiliated teaching hospital in Apeldoorn, The Nether-
lands. Between September 2000 and January 2007,
all admissions were screened for study participation
(Figure 1). The local ethics committee approved the study.
Informed consent was given by a proxy and, as soon as
possible, by the patients themselves. We classified the
patients of the AKI group according to the maximum
RIFLE (Risk, Injury, Failure, Loss, and End-stage kidney
disease) class [12] during their ICU stay and according to
urine output data. RIFLE was the current choice when the
study was completed. As baseline creatinine, the lowest
creatinine value measured in the 3 months before the
patient’s ICU admission (87.2% of the cases) or creatinine
calculated from the MDRD (Modification in Diet in Renal
Disease) was used [13]. Patients with pre-existing end-
stage renal disease were excluded. Patients with an
impaired level of self-awareness or without the ability to
communicate adequately at any time during the study
were also excluded. We evaluated HRQOL before admis-
sion (proxies), at ICU discharge (patients), at hospital dis-
charge (patients), and at 3 and 6 months (patients) after
ICU discharge. AKI patients and non-AKI patients
admitted for more than 48 hours were included in the
study. We included only patients with an ICU stay of
more than 48 hours because we aimed to evaluate the
sickest patients, hypothesizing that the impact of ICU stay
on HRQOL would be most prominent. Patients’ demo-
graphic data and severity of illness (Acute Physiology and
Chronic Health Evaluation II, or APACHE II) [14] were
also collected.
Health-related quality of life measurement
The Short-Form 36 (SF-36 version 1) [15], a widely used
generic standardized health status questionnaire, was used
to measure HRQOL. This measurement contains eight
multi-item dimensions: physical functioning (PF), role lim-
itation due to physical problems (RP), bodily pain (BP),
general health (GH), vitality (VT), social functioning (SF),
role limitation due to emotional problems (RE), and men-
tal health (MH). Computation of domain scores was per-
formed according to predefined guidelines [16]. Higher
scores represent better functioning, and the range of
scores was from 0 to 100. Furthermore, scores were aggre-
gated to summary measures representing a physical health
summary score (physical component score (PCS), mainly
reflecting physical functioning, physical role, pain, and
general health) and a mental health summary score (men-
tal component score (MCS), mainly reflecting vitality,
social functioning, emotional role, and mental health) [17].
Population scores on PCS and MCS have been standar-
dized on a population mean of 50 and a standard deviation
of 10 [18]. The SF-36 was validated in primary care for
members of the general population [18,19] and for asses-
sing HRQOL following critical illness [20,21]. Translation,
validation, and norming of the Dutch language version of
the SF-36 health questionnaire were evaluated in 1998 in
community and chronic disease populations [22].
As most of the patients are not able to complete a ques-
tionnaire at the time of admission, proxies have to be used
frequently as a surrogate approach. The use of proxies to
assess the patients’ HRQOL was validated in earlier studies
by our group by using the SF-36 [23] and the Academic
Medical Center Linear Disability score (ALDS) measuring
physical reserve [24]. Proxies had to be in close contact
with the patient on a regular basis. When necessary,
instructions and an explanation of the questionnaire were
given. Proxies were asked to answer on behalf of the
patient and mark the statement that best described the
patient’s state of health in the last 4 weeks prior to the
admission.
The first SF-36 questionnaire was completed within
48 hours of admission by using the standard time frame of
4 weeks. At the time of ICU discharge and hospital dis-
charge, the patients were specifically asked to score their
HRQOL according to their current situation. During hos-
pital admission, patients completed the questionnaire by
personal interview. All interviews were performed by the
same investigator (JGMH). After hospital discharge, the
questionnaire was completed by personal interview or was
conducted by telephone. Whenever it was necessary to do
so, the investigator (JGMH) visited the patients at home.
The average time required to complete the questionnaire
was 15 to 20 minutes. Furthermore, we compared
HRQOL before ICU admission and 6 months after ICU
discharge with those of the 60- to 70-year-old age group
of the general Dutch population [22] and used the first
question of the SF-36 as a measure of perceived overall
health status. This is the single-item question pertaining
to general health status: ‘In general, would you say your
health is excellent, very good, good, fair, or poor?’
Hofhuis et al. Critical Care 2013, 17:R17
http://ccforum.com/content/17/1/R17
Page 2 of 13
Renal replacement therapy (CVVH)
During the study period, the hemofiltration protocol and
machine (Multifiltrate machine (Fresenius Medical Care,
Homburg, Germany) were not changed. Continuous veno-
venous hemofiltration (CVVH) was performed by using an
AV600S filter (Fresenius Medical Care). A blood flow of
200 to 300 mL/minute was used, and the substitution flow
was set at 35 mL/kg per hour. Anticoagulation was
achieved by intravenous infusion of citrate into the affer-
ent line of the CVVH machine in accordance with a stan-
dard ICU protocol. No bolus of anticoagulation was given.
Two kinds of substitution fluids were used, depending on
base deficit: one bicarbonate-buffered (Multibic; Medical
Care, Homburg, Germany) and one buffer-free (HF281;
Medical Care).
Statistical analysis
As we aimed to assess how patients improved after ICU
discharge, we chose to analyze changes over time from
ICU discharge by using a linear mixed model for each
dimension of the SF-36 and by using the pre-ICU score as











































3775 patients screened 
during the study period 
3026 patients excluded: 
2405 pts ICU length of stay < 48 hours 
87 pts no close proxy 
98 family/pts refused informed consent 
186 pts re-admission 
12 pts not speaking sufficient Dutch 
73 pts cognitive impairment  
    (mentally impairment, dementia) 
20 pts transferred to another hospital 
145 pts due to investigator absence 
N= 172 included 
 with AKI 
N=577 included  
without AKI 
N=448 
discharged from the ICU 
N=367 
discharged from the 
hospital 
N=338  
follow up at 3 months 
after ICU discharge 
N=325  
follow up at 6 months 
after ICU discharge 
71 pts died during ICU 
32 pts transferred to other 
hospital, 26 pts neurological  
impairment i.e. delirium 
 61 pts died in ward 
20  pts lost to follow up 
(neurological impairment i.e. 
long-term delirium) 
25 pts died at 3 months 
 4 pts lost to follow up 
 
 
11 pts died at 6 months 
2 pt lost to follow up 
 
N= 99 
discharged from the ICU 
61 pts died during ICU 
12 pts lost to follow up 
(neurological impairment i.e. 
delirium) 
N= 79 
discharged from the 
hospital 
N= 74 
follow up at 3 months 
after ICU discharge 
N= 73 
follow up at 6 months 
after ICU discharge 
12 pts died in ward 
8 pts lost to follow up 
(neurological impairment i.e. 
long-term delirium)  
 5 pts died at 3 months 
 
 1 pts died at 6 months 
 
Figure 1 Flow diagram of the patients screened and included in the study. AKI, acute kidney injury; ICU, intensive care unit; Pts, patients.
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that each measurement of each subject is used, regardless
of time of drop-out (like mortality). These models are less
biased than complete-case analyses, as the ‘worse’ patients
who eventually drop out of the study are included as
much as possible in the estimations. The improvement
from ICU discharge is estimated by using data obtained
from patients; the proxy assessment is used only to correct
for differences in pre-ICU HRQOL between patients. We
made the following choices in the linear mixed model: a
random intercept model, in which patients were included
as a random effect; fixed effects included time, pre-ICU
score, APACHE II score, age, AKI/non-AKI, and the inter-
action between time and AKI/non-AKI (to check whether
both groups showed a different pattern of change over
time); the final estimation method was restricted maxi-
mum likelihood. The assumption of normality of the resi-
duals was assessed by a Q-Q plot. Estimates of domain
scores at different time points are presented with 95% con-
fidence intervals. To present the simplest possible mode,
we tested whether random slopes needed to be included
in the model. We chose to report the models with random
slopes for time, as these were significantly better than
models without random slopes in all domains. We also
analyzed the change over time from ICU discharge for the
different RIFLE criteria groups (Risk, Injury, and Failure)
within the AKI group and the change over time of patients
treated with CVVH within the AKI group. For the com-
parison of pre-admission versus 6 months, we could not
use the linear mixed model, as the pre-admission score
was included in that model as a covariate. Therefore, we
performed an analysis of covariance (ANCOVA) (that is, a
general linear model) with Bonferroni correction (signifi-
cance level P < 0.05) to detect differences in the SF-36
scores at admission between survivors and non-survivors
and to assess changes between pre-ICU and 6 months
after ICU discharge (repeated measures ANCOVA). A sta-
tistical adjustment was made for age, sex, and APACHE II
score by including these variables as covariates. SF-36
dimensions of survivors were compared with normative
data from the 60- to 70-year-old age group from the
Dutch normal population [22] by using the one-sample
t test. The significance level was adjusted by Bonferroni
correction according to the number of related tests con-
ducted. To examine the relative magnitude of changes
over time and between groups, effect sizes were used on
the basis of the mean change found in a variable divided
by the baseline standard deviation. Effect sizes estimate
whether particular changes in health status are relevant. In
keeping with Cohen, effect sizes of at least 0.20, at least
0.50, and more than 0.80 were considered small, medium,
and large changes, respectively [26]. To illustrate the course
of HRQOL over time, we plotted raw (uncorrected) data.
Groups were defined on the length of follow-up (that is,
ranging from only pre-ICU to 6 months after discharge).
Chi-squared tests were used to assess the demographic dif-
ferences between ICU survivors and ICU non-survivors.
Data were analyzed by using the Statistical Package for the
Social Sciences (version 17; SPSS Inc., Chicago IL, USA)
and the Linear mixed-effects models (MIXED) procedure.
All data are expressed as mean ± standard deviation where
appropriate unless otherwise indicated.
Results
During the study period, 3,775 patients were screened for
study participation. We included a total of 749 patients
(Figure 1): 172 with AKI (61.6% were men and 38.4% were
women) and 577 without AKI (60.5% were men and 39.5%
were women) (Table 1). A baseline HRQOL was obtained
from all patients who were evaluated in the final analysis
(n = 749). Of the patients with/without AKI, HRQOL was
measured at ICU discharge (n = 99/448), at hospital dis-
charge (n = 79/367), and at 3 months (n = 74/338) and
6 months (n = 73/325). Lost to follow-up were 20/26
patients (mental impairment or long-term delirium)
(Figure 1). The demographic and clinical characteristics of
the patients lost to follow-up did not differ from those of
the group analyzed in the study (data not shown).
Among 172 patients with AKI, 30.2% were classified
according the RIFLE criteria as risk, 30.8% as injury, and
39% as failure. Of the AKI group, 113 patients (65.7%) were
treated with CVVH; of the non-AKI group, 13 patients
(2.3%) were treated with CVVH. Mortality rates at 6 months
were 46.5% in the group with AKI and 29.1% in the group
without AKI (Table 2). ICU and hospital lengths of stay
and ventilation days were significantly higher in the total
group with AKI compared with the total group without
AKI. Demographic and clinical characteristics of all patients
are shown in Tables 1 and 2.
Patients with AKI and those without AKI
Changes over time in patients with AKI and those without AKI
Most SF-36 dimensions, except for bodily pain and role-
emotional, changed significantly over time from ICU dis-
charge (Additional file 1). Pre-ICU HRQOL score was a
significant predictor of change but not APACHE II score,
AKI RIFLE classes, or treatment with CVVH within the
AKI group. Change over time of HRQOL between the dif-
ferent AKI Rifle classes (Risk, Injury, and Failure) showed
no significant differences. Age was a significant predictor of
change in the physical functioning dimension only. At ICU
discharge, scores were lowest in the group with AKI com-
pared with the group without AKI for the physical func-
tioning, role-physical, and general health dimensions. In
both groups, physical functioning was far lower than
mental functioning. Surprisingly, bodily pain had a high
(that is, positive) score. The course of HRQOL over time of
patients with AKI is illustrated in Figure 2 as uncorrected
values (that is, not derived from the linear mixed model).
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Number (percentage) 172 52 (30.2) 53 (30.8) 67 (39.0) 577 73 325 P value P value




71 (63-77) 67 (54.5-74.0) 69 (61.3-76) 0.898 0.424
Males, number (percentage) 106 (61.6) 39 (22.7) 31 (36.0) 36 20.9) 350 (60.5) 44 (60.3) 190 (58.6) < 0.001 < 0.001
Females, number (percentage) 66 (38.4) 13 (7.6) 22 (12.8) 31 (36.0) 227 (39.5) 29 (39.7) 134 (41.4) < 0.001 < 0.001




21 (18-26) 17 (13-21) < 0.001 < 0.001
ICU length of stay, days 13.5 (6-27) 16 (8.2-
25.7)
11 (6-22) 12 (6-28) 7 (5-13) 10 (6-18) 7 (5-12) < 0.001 0.002




24 (13-54) 30 (17-
63)
22 (13-37) 35 (20-61.5) 26 (16-41.8) 0.023 0.058




9 (3.5-16.5) 9 (2-24) 5 (3-10) 6 (2-13.5) 5 (3-8.7) < 0.001 0.002
Diagnostic groups, number
(percentage)
Cardiovascular pathology 73 (42.4) 20 (20.8) 24 (12.5) 29 (15.1) 111 (19.2) 33 (45.2) 64 (19.8) 0.006 0.02
Respiratory pathology 48 (27.9) 18 (9.4) 11 (5.7) 19 (9.9) 196 (34.0) 20 (27.4) 97 (29.9) < 0.001 < 0.001
Gastrointestinal pathology 45 (26.2) 12 (6.3) 16 (8.3) 17 (8.9) 214 (37.1) 19 (26.0) 139 (42.9) < 0.001 < 0.001
Neurological pathology 2 (1.2) 1 (0.51) - 1 (0.51) 28 (4.9) - 7 (2.2) - -
Trauma 1 (0.6) - 1 (0.51) - 22 (3.8) - 14 (4.3) - -
Others 3 (1.7) 1 (0.51) 1 (0.51) 1 (0.51) 6 (1.0) 1 (1.4) 3 (0.9) 0.317 0.317
Type of admission, number
(percentage)
Non-surgical 110 (64.0) 34 (19.8) 28 (16.3) 48 (27.9) 305 (52.9) 48 (65.8) 138 (42.6) < 0.001 < 0.001
Emergency surgical 50 (29.1) 15 (8.7) 23 (13.4) 12 (7.0) 207 (35.9) 20 (27.4) 138 (42.6) < 0.001 < 0.001
Elective surgical 12 (7.0) 3 (1.7) 2 (1.2) 7 (4.1) 65 (11.3) 5 (6.8) 48 (14.8) < 0.001 < 0.001
Type of proxy, number (percentage)
Spouse 97 (56.4) 26 (15.3) 35 (20.6) 36 (21.2) 412 (71.4) 51 (69.9) 257 (79.3) < 0.001 < 0.001
Children 72 (41.9) 30 (17.6) 30 (17.6) 10 (5.9) 157 (27.2) 22 (30.1) 59 (18.2) < 0.001 < 0.001
Brother/Sister 3 (1.7) 1 (0.6) 2 (1.2) - 8 (1.4) - 8 (2.5) - -
Elective surgical: intensive care unit (ICU) admission was planned within a 24-hour period before surgery. Emergency surgical: unplanned surgery. Non-surgical: all other admissions. Values are presented as median













Comparison of pre-admission (by proxy) and 6-month
HRQOL of survivors with AKI and those without AKI
Pre-admission HRQOL showed no significant differences
in any SF-36 dimensions between survivors with AKI and
those without AKI. At 6 months, the mean scores of the
survivors with AKI were significantly lower in two dimen-
sions - vitality (P = 0.016; effect size 0.25) and general
health (P = 0.039; effect size 0.22) - compared with the
survivors without AKI.
Patients with AKI
Comparison of AKI survivors’ pre-admission HRQOL (by
proxy) with that of the general population
The pre-admission HRQOL of AKI survivors was signifi-
cantly lower in two dimensions - vitality (P < 0.001) and
mental health (P < 0.001) - when compared with an age-
matched general population (Table 3 and Figure 3). The
significant difference of the bodily pain dimension was
based on a higher mean pre-admission score compared
with the general population.
Comparison of AKI survivors’ pre-admission HRQOL with
that of non-survivors (by proxy)
Pre-admission HRQOL of AKI non-survivors was signifi-
cantly lower in three dimensions - social functioning (P =
0.014), mental health (P = 0.021), and bodily pain (P =
0.029) - compared with that of AKI survivors (Table 3).
Comparison of AKI survivors’ pre-admission HRQOL (by
proxy) with HRQOL at 6 months
Six months after ICU discharge, four dimensions - physi-
cal functioning (P = 0.014), role-physical (P = 0.027), gen-
eral health (P = 0.001), and the PCS (P < 0.001) - were still
significantly lower compared with their pre-admission
levels (n = 73) in survivors with AKI (Table 3).
Comparison of AKI survivors’ 6-month HRQOL with that of
the general population
The 6-month HRQOL of AKI survivors was significantly
lower in all dimensions except role-emotional (P = 0.152).
The significant difference of the bodily pain dimension
was based on a higher mean 6-month score compared
with the general population (Table 3 and Figure 3).
Patients without AKI
Comparison of pre-admission HRQOL (by proxy) of
survivors without AKI with that of the general population
The pre-admission HRQOL of survivors without AKI was
significantly lower in three dimensions - vitality (P <
0.001), mental health (P < 0.001), and social functioning
(P = 0.001) - when compared with the age-matched gen-
eral population (Table 4 and Figure 3). The significant dif-
ference of the bodily pain dimension was based on a
higher mean pre-admission score compared with the gen-
eral population.
Comparison of pre-admission HRQOL (by proxy) in
survivors with that of non-survivors without AKI
Pre-admission HRQOL was significantly lower in all
dimensions of the SF-36, except bodily pain, of non-survi-
vors without AKI compared with the survivors without
AKI (Table 4).
Comparison of pre-admission HRQOL (by proxy) with
HRQOL at 6 months in survivors without AKI
In the patients without AKI, five dimensions were
significantly lower at 6 months compared with their









































- - < 0.001 -
RIFLE, number
(percentage) Risk













13 (2.3) 39 (53.4) 8 (2.5) < 0.001 0.798








4 (2-12) 3 (1.3-4.5) 0.567 0.757
Chronic intermittent
hemo-dialysis
15 - - - - - - - -
Renal transplant 2 - - - - - - - -
CVVH, continuous venovenous hemofiltration; RIFLE, Risk, Injury, Failure, Loss, and End-stage kidney disease.
Hofhuis et al. Critical Care 2013, 17:R17
http://ccforum.com/content/17/1/R17









pre icu dis hosp dis 3m 6m














pre icu dis hosp dis 3m 6m





Figure 2 Course of physical component score and mental component score over time with different survival time of patients with
acute kidney injury. 3 m, 3 months after intensive care unit (ICU) discharge; 6 m, 6 months after ICU discharge; 3 m surv, survivors 3 months
after ICU discharge; 6 m surv, survivors 6 months after ICU discharge; hosp dis, hospital discharge; hosp surv, hospital survivors; ICU dead, dead
at ICU discharge; ICU dis, ICU discharge; ICU surv, survivors at ICU discharge; Pre, before ICU admission.
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PCS 40.6 ± 12.6 42.3 ±
12.7
26.3 ± 5.9 31.2 ± 7.6 35.9 ± 10.8 37.1 ± 11.3 - 0.158 0.39 - - 0.001d 0.46 - -
MCS 47.9 ± 10.6 49.7 ± 9.9 46.3 ± 9.4 47.5 ± 9.8 50.8 ± 9.2 49.9 ± 9.1 - 0.051 0.27 - - 0.924 0.02 - -
PF 58.7 ± 33.9 62.5 ±
34.2
6.01 ± 12.8 25.5 ± 22.9 48.6 ± 31.4 51.5 ± 32.9 71.7 ± 25.6 0.450 0.28 0.025 0.36 0.014d 0.32 < 0.001d 0.61
RP 46.1 ± 47.1 51.4 ±
48.9
13.1 ± 31.2 14.2 ± 33.2 26.7 ± 41.0 35.6 ± 42.1 67.3 ± 40.9 0.144 0.32 0.007 0.39 0.027d 0.32 < 0.001 d 0.75
BP 78.0 ± 25.6 82.4 ±
25.2
79.0 ± 22.3 83.1 ± 21.3 82.6 ± 24.3 79.4 ± 24.7 70.5 ± 24.6 0.029d 0.38 < 0.001d 0.48 0.485 0.12 0.003d 0.36
GH 48.9 ± 29.3 54.0 ±
29.3
29.0 ± 18.3 36.4 ± 21.5 42.1 ± 22.7 41.2 ± 21.2 61.7 ± 20.2 0.094 0.37 0.028 0.36 0.001d 0.44 < 0.001d 0.96
VT 52.9 ± 25.2 55.5 ±
27.5
31.4 ± 15.3 44.2 ± 18.3 54.7 ± 20.5 53.3 ± 22.3 67.7 ± 19.6 0.336 0.20 < 0.001d 0.52 0.993 0.07 < 0.001d 0.64
SF 72.0 ± 24.3 77.6 ±
23.7
49.2 ± 22.9 58.2 ± 23.4 68.7 ± 25.4 72.9 ± 24.6 82.0 ± 24.6 0.014d 0.44 0.115 0.19 0.202 0.19 0.002d 0.37
RE 70.3 ± 42.3 75.8 ±
40.6
67.7 ± 42.4 62.0 ± 47.1 80.6 ± 37.8 73.9 ± 42.0 81.1 ± 35.0 0.166 0.25 0.268 0.04 0.948 0.04 0.152 0.17
MH 66.4 ± 17.3 69.7 ±
16.1
56.0 ± 11.2 62.3 ± 13.3 67.4 ± 14.0 67.3 ± 13.2 76.9 ± 17.9 0.021d 0.40 < 0.001d 0.55 0.246 0.15 < 0.001d 0.54
Effect sizes of at least 0.20, at least 0.50, and greater than 0.80 correspond to small, medium, and large, respectively. Values are presented as mean ± standard deviation (SD). aUnivariate analysis of variance with
Bonferroni correction P < 0.05 significant. bOne-sample t test. cGeneral linear model repeated measures with Bonferroni correction P < 0.05 significant. dP value significant after Bonferroni correction (P 0.05/10 = P =
0.005 = significant). SF-36 (Medical Outcomes Study 36-item Short-Form) dimension scores range from 0 to 100. Physical component score (PCS) and mental component score (MCS) are converted to mean 50 (SD 10).













pre-admission HRQOL: physical functioning (P < 0.001),
role-physical (P < 0.001), general health (P < 0.001), social
functioning (P = 0.011), and the PCS (P < 0.001). The sig-
nificant difference of the bodily pain dimension was based
on a higher mean 6-month score compared with pre-
admission (Table 4).
Comparison of 6-month HRQOL of survivors without AKI
with that of the general population
The 6-month HRQOL of survivors without AKI was sig-
nificantly lower in all dimensions except role-emotional
(P = 0.027). The significant difference of the bodily pain

































survivors 6 months n=325
general population
Figure 3 Comparison of survivors with acute kidney injury (AKI) (n = 73) and those without AKI (n = 325) before intensive care unit (ICU)
admission, 6 months after ICU discharge, and the general Dutch population. BP, bodily pain; GH, general health; MH, mental health; PF, physical
functioning; RE, role limitation due to emotional problems; RP, role limitation due to physical problems; SF, social functioning; VT, vitality.
Hofhuis et al. Critical Care 2013, 17:R17
http://ccforum.com/content/17/1/R17
Page 9 of 13





















































PCS 41.5 ± 13.6 44.0 ± 12.9 26.6 ± 6.5 32.5 ± 9.2 36.8 ± 10.5 39.1 ± 11.1 - < 0.001d 0.57 - - < 0.001d 0.38 - -
MCS 48.5 ± 10.3 50.1 ± 9.9 46.1 ± 9.3 47.9 ± 9.5 49.7 ± 10.9 50.7 ± 10.9 - < 0.001d 0.35 - - 0.241 0.06 - -
PF 59.6 ± 34.6 66.6 ± 33.2 6.4 ± 12.9 30.8 ± 26.4 49.0 ± 32.4 54.3 ± 31.8 71.7 ± 25.6 < 0.001d 0.59 0.006 0.20 < 0.001d 0.37 < 0.001d 0.68
RP 52.5 ± 47.4 60.9 ± 46.7 14.4 ± 32.5 19.6 ± 35.7 28.9 ± 40.5 39.7 ± 45.6 67.3 ± 40.9 < 0.001d 0.54 0.014 0.16 < 0.001d 0.45 < 0.001d 0.67
BP 79.0 ± 26.9 80.2 ± 27.3 75.1 ± 25.0 82.1 ± 22.8 80.7 ± 24.0 84.0 ± 22.2 70.5 ± 24.6 0.238 0.14 < 0.001d 0.39 0.033d 0.14 < 0.001d 0.55
GH 50.9 ± 30.3 57.9 ± 28.9 31.1 ± 19.6 38.8 ± 27.4 44.7 ± 26.4 46.8 ± 24.9 61.7 ± 20.2 < 0.001d 0.57 0.019 0.19 < 0.001d 0.38 < 0.001d 0.74
VT 53.6 ± 24.1 58.9 ± 24.2 32.7 ± 15.9 44.9 ± 18.2 55.9 ± 22.8 58.9 ± 21.7 67.7 ± 19.6 < 0.001d 0.59 < 0.001d 0.45 0.610 0.10 < 0.001d 0.36
SF 71.8 ± 24.7 77.5 ± 24.6 52.1 ± 22.5 60.4 ± 24.8 69.1 ± 27.8 72.5 ± 24.8 82.0 ± 24.6 < 0.001d 0.56 0.001d 0.18 0.011d 0.20 < 0.001d 0.39
RE 74.8 ± 40.9 79.3 ± 39.0 60.9 ± 44.3 68.2 ± 45.6 70.0 ± 43.2 75.9 ± 40.9 81.1 ± 35.0 0.010d 0.29 0.412 0.05 0.383 0.08 0.027 0.15
MH 67.5 ± 16.7 70.9 ± 15.9 56.9 ± 11.5 63.1 ± 13.0 67.6 ± 16.1 69.2 ± 21.5 76.9 ± 17.9 < 0.001d 0.50 < 0.001d 0.34 0.461 0.08 < 0.001d 0.43
Effect sizes of at least 0.20, at least 0.50, and greater than 0.80 correspond to small, medium, and large, respectively. Values are presented as mean ± standard deviation (SD). aUnivariate analysis of variance with
Bonferroni correction P < 0.05 significant. bOne-sample t test. cGeneral linear model repeated measures with Bonferroni correction P < 0.05 significant. dP value significant after Bonferroni correction (P 0.05/10 = P =
0.005 = significant). SF-36 (Medical Outcomes Study 36-item Short-Form) dimension scores range from 0 to 100. Physical component score (PCS) and mental component score (MCS) are converted to mean 50 (SD














compared with the general population (Table 4 and
Figure 3).
Discussion
The main finding of the present study is that survivors
with AKI and those without AKI showed almost no sig-
nificant differences between the HRQOL 6 months after
ICU discharge, suggesting that AKI survivors do not have
a perceived lower HRQOL outcome than ICU survivors
without AKI. Our study results showed that, in survivors
with AKI and those without AKI, the pre-admission
HRQOL (by proxy) was significantly lower compared
with the age-matched general population. At 6 months
after ICU discharge, HRQOL in survivors of both groups
was lower than pre-ICU admission HRQOL. Further-
more, HRQOL of survivors of both groups at 6 months
was far lower than that of the general population. These
differences in results at 6 months can be due to the dif-
ferent means of taking measures.
Interestingly, hospital length of stay was longer in the
AKI survivors compared with the total AKI group, which
was obviously affected by death. Thereby, patients with
AKI (total group) had a significantly longer ICU length of
stay and ventilation days than patients without AKI (total
group), and this may have important implications for
resource utilization. In particular, the longer ICU and
hospital stays may be associated with a higher rate of
transfer to a long-term care or rehabilitation facility after
hospital discharge [27,28]. In our study, mortality of the
AKI group was high (46.5%). Renal failure severe enough
to require RRT has been associated with a high mortality
in various studies [29-31] (that is, mortality rates of 55%
to 62% at 6 months and 65% at 5 years [3]). In line with
our study findings, the majority of deaths occurred dur-
ing ICU stay. Gopal and colleagues [6] and Morgera and
colleagues [7], on the other hand, have reported much
higher mortality rates over a similar follow-up time. This
is likely due to differences in the severity of illness or due
to time bias. Previous studies reported a prevalence of
RIFLE-defined AKI at the time of ICU admission of
between 22% and 36%, which is comparable to our find-
ings (23%) [1,32]. The total group of included patients in
our study showed an AKI risk prevalence comparable to
that of a recent study [33], although the AKI injury and
failure group were both smaller than in our study. How-
ever, we included patients with AKI at the time of ICU
admission or during ICU stay, and this may partly explain
these differences.
Furthermore, our study revealed that, in survivors with
AKI and those without AKI, the pre-admission HRQOL
(by proxy) was significantly lower (respectively, three and
four dimensions) compared with that of the age-matched
general population. These findings are in accord with other
studies in which many patients requiring ICU actually have
a lower HRQOL before ICU admission [9,34]. An impor-
tant shortcoming of many studies in the field of long-term
prognosis in patients with AKI is the lack of knowledge
regarding the HRQOL before ICU stay [35]. When there is
no baseline measure of HRQOL, investigators are unable
to conclude whether the limitations in HRQOL are due to
pre-existing chronic illness or due to the acute condition
[8]. However, owing to the patient’s condition at admission,
assessment of ICU pre-admission scores is rarely possible.
Considering the positive results of our earlier validation
study [23] and comparable results from other studies
[20,36], we chose to use proxies for pre-admission scores.
Concerns about proxy estimations of HRQOL in popula-
tions with high disease severity [37] are probably based on
major differences in timing of assessments of HRQOL:
interviewing patients 3 months after ICU discharge and
their proxies at study entry. It is likely that the critical ill-
ness may influence the patients’ retrospective recollection
of their previous health (recall bias) and that they may
overestimate their previous health.
Interestingly, in our study, survivors with AKI and
those without AKI showed no significant differences
between the HRQOL 6 months after ICU discharge,
except for the vitality and general health dimensions.
However, both groups showed a significantly lower
HRQOL at 6 months compared with an age-matched
general population. Recently, Orwelius and colleagues
[38] divided their study group and the reference group
into the previously healthy and those having pre-existing
disease and reported that a large reduction of HRQOL
after ICU is attributable to pre-existing disease. How-
ever, the Dutch general population, based on age, gen-
der, and chronic health conditions, does not include a
group with no pre-existing disease [22], making it diffi-
cult to perform this comparison. Some earlier studies
have reported a fairly good HRQOL after AKI [2,3,6].
Korkeila and colleagues [3] reported that, predomi-
nantly, overall energy and the physical domain were
impaired. However, a limitation of that study is that the
patients were not compared with the general population.
Most critical care professionals consider the perception
of post-discharge HRQOL to be important in their
decisions concerning the allocation of intensive care
resources [6].
As in our study, Ahlstrom and colleagues [5] investi-
gated the survival and quality of life of patients with AKI/
requiring RRT and found also a rather low HRQOL com-
pared with the general population. Comparable findings
were reported by Noble and colleagues [8].
Contrary to our findings, other studies found mental
health to be comparable and their physical health to be
only slightly poorer than that of the general population
[2,3]. The results of our study revealed that, at 6 months,
physical health was affected more seriously than mental
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health. These findings concur with those of Delannoy
and colleagues [39], who reported that, at 6 months,
HRQOL was lower in patients with AKI/RRT than in an
age-matched general population. However, in contrast
with our study, in the study by Delannoy and colleagues
[39] and in the study by Noble and colleagues [8], there
was no assessment of HRQOL on ICU admission.
Interestingly, Maynard and colleagues [2] reported
that almost all patients, even those with the worst self-
reported quality of life and greatest physical disability,
considered RRT to have been the right decision. Most
survivors valued their lives highly, regardless of their
self-reported HRQOL, and in retrospect agreed with the
decision to continue aggressive care, including renal
replacement therapy [2]. In line with the study by May-
nard and colleagues [2], the perceived overall state of
HRQOL (using the first question of the SF-36) of the
surviving patients with AKI and those without AKI
seemed acceptable and showed no significant difference
between the two groups. This is also illustrated by the
findings of our study that, in contrast to impairment in
physical dimensions, perceived mental health seems to
be less impaired [8]. Finally, the pre-admission HRQOL
of the non-survivors in our study was significantly lower
compared with survivors in the group without AKI.
Interestingly, in the AKI group, this was the case in only
a few dimensions, possibly owing to the smaller group
of patients with AKI.
Several limitations to our study should be men-
tioned. First, we included only patients on their first
admission who also stayed in the ICU for more than
48 hours. Therefore, the results are not generalizable
to the group of patients with a short ICU stay. Second,
as mentioned above, we chose to use proxies for pre-
admission scores, instead of a retrospective assessment
at ICU discharge. This was done because the critical
illness may influence the patients’ recollection of their
previous health and the approach of using proxies
in this setting was validated in an earlier study by our
group [23] and by other studies [20,36]. It is known
that proxies may differ in their assessment from
patients themselves, but our earlier results showed that
these differences were small. However, the results
between proxy and ICU patient measures should be
interpreted with caution.
Third, the presence of delirium could have influenced
the response, although we made an effort to identify delir-
ious patients. Finally, we cannot rule out that response
shift played a role in our study population (that is, self-
evaluation changes resulting from changes in internal
standards or values in patients confronted with a life-
threatening disease or chronic incurable disease [40]).
Social functioning, for instance, could be perceived
differently in the clinical setting because of the many visi-
tors in the hospital and cards received.
Conclusions
Six months after ICU discharge, survivors with AKI and
those without AKI showed a nearly similar HRQOL.
However, HRQOL is poorer in both groups compared
with the general population with a similar age.
Key messages
• Health-related quality of life (HRQOL) outcome of
acute kidney injury (AKI) survivors was nearly similar
to that of intensive care unit (ICU) survivors without
AKI.
• Patients with AKI and those without AKI demon-
strated that recovery of HRQOL was not complete at
6 months after ICU discharge in comparison with
their pre-admission HRQOL.
• HRQOL was lower at 6 months after ICU discharge
in patients with AKI and those without AKI com-
pared with that of a general population.
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Additional file 1: Estimates of change over time of HRQOL from ICU
discharge in the patients with and without AKI. Changes over time of
Short-Form 36 dimensions in patients with and without AKI.
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